Apellis Pharmaceuticals to Host a Fireside Chat at the UBS Virtual Ophthalmology Day

Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) has announced its participation in the UBS Virtual Ophthalmology Day. The company will host a fireside chat on Wednesday, October 2, 2024, at 8:30 a.m. ET. This event will be accessible through a live webcast on the company's website, specifically on the "Events and Presentations" page within the "Investors and Media" section.

For those unable to attend the live event, Apellis will provide a replay of the webcast, which will remain available for approximately 90 days following the event. This virtual participation underscores Apellis' commitment to engaging with investors and industry professionals in the ophthalmology sector.

WALTHAM, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a fireside chat at the UBS Virtual Ophthalmology Day on Wednesday, October 2, 2024, at 8:30 a.m. ET.

The live event webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first and only therapy for geographic atrophy, a leading cause of blindness around the world. We believe we have only begun to unlock the potential of targeting C3 across serious retinal, rare, and neurological diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.

Investor Contact: 
Meredith Kaya 
meredith.kaya@apellis.com
617.599.8178

FAQ

When is Apellis Pharmaceuticals (APLS) participating in the UBS Virtual Ophthalmology Day?

Apellis Pharmaceuticals (APLS) is participating in the UBS Virtual Ophthalmology Day on Wednesday, October 2, 2024, at 8:30 a.m. ET.

What type of event is Apellis Pharmaceuticals (APLS) hosting at the UBS Virtual Ophthalmology Day?

Apellis Pharmaceuticals (APLS) is hosting a fireside chat at the UBS Virtual Ophthalmology Day.

How can investors access Apellis Pharmaceuticals' (APLS) fireside chat at the UBS Virtual Ophthalmology Day?

Investors can access the live webcast of Apellis Pharmaceuticals' (APLS) fireside chat on the "Events and Presentations" page of the "Investors and Media" section on the company's website.

How long will the replay of Apellis Pharmaceuticals' (APLS) UBS Virtual Ophthalmology Day fireside chat be available?

The replay of Apellis Pharmaceuticals' (APLS) fireside chat will be available for approximately 90 days following the event.